Survival following treatment of a cardiac malignant fibrous histiocytoma. Chest 2000 Jul;118(1):271-3
Date
07/14/2000Pubmed ID
10893397DOI
10.1378/chest.118.1.271Scopus ID
2-s2.0-0033931224 (requires institutional sign-in at Scopus site) 19 CitationsAbstract
The authors report the successful surgical and chemotherapeutic management of a malignant fibrous histiocytoma with localization in the heart. This rare malignancy has specific morphologic characteristics and is diagnosed in adults when it is already locally aggressive or metastasized. The average survival time for patients with malignant fibrous histiocytoma is < 12 months. Neither clinical nor instrumental signs of recurrence have been detected in this patient after an aggressive surgical resection and a specific therapeutic approach.
Author List
Schena S, Caniglia A, Agnino A, Caruso G, Ferlan GAuthor
Stefano Schena MD, PhD Associate Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedChemotherapy, Adjuvant
Female
Heart Neoplasms
Histiocytoma, Benign Fibrous
Humans